The Global On Body Drug Delivery Devices Market reached US$ 40.54 billion in 2024 and is expected to reach US$ 82.74 billion by 2033, growing at a CAGR of 8.6% during the forecast period 2025-2033.
The On-Body Drug Delivery Devices market report provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Leveraging a combination of qualitative and quantitative research methods, the company offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://shorturl.at/tOWSq
On-body drug delivery devices are wearable systems designed to administer medication subcutaneously over a specified period. These devices provide a convenient alternative to injections, improving patient adherence and comfort. They are commonly used for biologics, insulin, and chemotherapy drugs. Advanced models feature connectivity for real-time monitoring and dose adjustments. Their growing adoption is driven by the demand for at-home treatments and personalized medicine.
Forecast Growth Projected:
The Global On-Body Drug Delivery Devices Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2033. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
List of the Key Players in the On-Body Drug Delivery Devices Market:
BD, Gerresheimer AG, NOVO Engineering, West Pharmaceutical Services, Inc., Enable Injections, Stevanato Group, LTS Lohmann Therapie-Systeme AG, Coherus BioSciences, Inc., Tandem Diabetes Care, Inc, Battelle.
Emerging Players
Hera Health Solutions, Vensica Medical, and Bigfoot Biomedical among others.
Transform your pharma strategy with expert insights and competitive analysis. Learn more @ https://www.datamintelligence.com/competitive-intelligence/contact
Industry Development:
➠ FDA Approves UDENCYA ONBODY™ Injector (Dec 2024)
Coherus BioSciences secured FDA approval for the UDENCYA ONBODY™ Injector, a pegfilgrastim delivery device for neutropenia treatment, competing with Amgen's Neulasta Onpro.
➠ Approval of enFuse Injector (Jan 2025)
Enable Injections' enFuse on-body injector received approval for Apellis' EMPAVELI (pegcetacoplan), enabling convenient self-administration of high-volume injections.
➠ BD Medical Unveils New Injectors (Jan 20, 2025)
BD Medical launched the BD Evolve™ (up to 3 mL) and BD Libertas™ (larger doses) on-body injectors, enhancing patient convenience and treatment adherence.
Research Methodology
Our research methodology combines both qualitative and quantitative approaches to provide you with a thorough market analysis. We begin by gathering data from trusted industry reports and databases (secondary research), followed by primary research through surveys and interviews with key experts. We then apply advanced statistical tools to analyze the data, uncover trends, and assess market dynamics. Additionally, we use market segmentation and Porter's Five Forces analysis to evaluate competition. This approach ensures that the insights we provide are reliable, actionable, and tailored to support your decision-making process.
Segment Covered in the On-Body Drug Delivery Devices Market:
By Devices Type: Wearable Injectors, Infusion Pumps, Others.
By Molecule Type: Small Molecule, Large Molecule.
By Application: Cardiovascular Diseases, Cancer, Diabetes, Auto-immune Disease, Others.
By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.
This Report Covers:
✔ Go-to-market Strategy.
✔ Neutral perspective on the market performance.
✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, Market Access, and other significant analysis, as well as development status.
✔Customized regional/country reports as per request and country level analysis.
✔ Potential & niche segments and regions exhibiting promising growth covered.
✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Regional Analysis for On-Body Drug Delivery Devices Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Top-down and bottom-up approach for regional analysis
➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market
Frequently asked questions:
➠ What is the global sales value, production value, consumption value, import and export of On-Body Drug Delivery Devices market?
➠ Who are the global key manufacturers of the On-Body Drug Delivery Devices Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?
➠ What are the On-Body Drug Delivery Devices market opportunities and threats faced by the vendors in the global On-Body Drug Delivery Devices Industry?
➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?
➠ What focused approach and constraints are holding the On-Body Drug Delivery Devices market?
➠ What are the different sales, marketing, and distribution channels in the global industry?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
